Skip to main content

Table 4 The activity evaluation of constituents from XCHD in HCoV-229E induced CPE reduction assay

From: Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus

Compound

Pubchem ID

TC50 a

IC50 b

SIc

Source

Structure

Isoliquiritigenin

638278

12.93

1.85

6.98

Chaihu; Zhigancao

Eleutheroside E

71312557

 > 50

50

 > 1.0

Renshen

Ginsenoside Rb1

9898279

 > 50

50

 > 1.0

Renshen

Kaempferide

5281666

28.87

16.67

1.73

Chaihu; Renshen

Citric acid

311

 > 50

50

 > 1.0

Chaihu; Renshen; Dazao

Citropten

2775

28.87

16.67

1.73

Chaihu; Shengjiang

6-Shogaol

5281794

3.21

1.44

2.23

Banxia; Shengjiang

( +)-Catechin Hydrate

107957

 > 50

38.8

 > 1.29

Dazao

Betulinic acid

64,971

16.67

0.36

46.77

Dazao

(20R)-Ginsenoside Rh1

21599923

 > 50

9.62

 > 5.20

Renshen

Methyl salicylate

4133

 > 50

34.67

 > 1.44

Chaihu

View full size image

Scopoletin

5280460

 > 50

50

 > 1.0

Chaihu; Dazao

Chrysin

5281607

34.67

4.63

7.49

Huangqin

Schisandrin B

108130

28.87

4.31

6.7

Renshen

Ginsenoside Rg3

9918693

 > 50

16.67

 > 3.0

Renshen

L-(-)-Fucose

3034656

 > 50

28.87

 > 1.73

Renshen

Paeonol

11092

 > 50

50

 > 1.0

Banxia; Renshen

Ribavirind

37542

 > 100

2.2 ± 0.87

 > 49.44 ± 19.59

-

  1. aTC50: 50% cytotoxic concentration (μg/ml)
  2. bIC50: 50% effective concentration (μg/ml)
  3. cSI: Selection index, TC50/IC50
  4. dPositive control drug